Top 50 Biotech Startup Investors in Finland in January 2026

Investor	Biotech Finland investments
Business Finland	10
Tesi	9
Voima Ventures	9
Lifeline Ventures	9
Finnvera Venture Capital	8
Butterfly Ventures	5
Springvest	5
Icebreaker.vc	4
Innovestor	3
Nordic Foodtech VC	3
Stephen Industries	3
Finnish Climate Fund	2
Inventure	2
Leena Niemistö	2
Sauli Törmälä	2
Nordic Science Investments	2
European Investment Bank	2
Sofinnova Partners	2
Pontos Group	2
VTT Ventures	2
Fazer	2
Broadview Ventures	2
EQT Life Sciences	2
HealthCap	2
Sitra	2
Mikael Westerlund	1
Jorma Ollila	1
University of Helsinki	1
Conor Venture Partners	1
Zhejiang Huahai Pharmaceutical	1
Midinvest Management	1
Green Campus Innovations Oy	1
Metsola Ventures	1
Novartis Venture Fund	1
Valio	1
Petri Pöyhönen	1
Haakon Overli	1
Wave Ventures	1
Creathor Ventures	1
Stockholm Techstars Accelerator	1
Aqua Spark	1
Emerald Technology Ventures	1
Kristian Ranta	1
Athensmed	1
Feroz Dewan	1
Riitta Ekengren	1
Ananda Impact Ventures	1
The Forum Corporation	1
Oy Hammaren & Co Ab	1
Granström Mari	1

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Investment focus

Software, SaaS, Biotechnology
Seed, Grant, Funding Round
Finland, United States, United Kingdom

Portfolio highlights

AIATELLA — Automating medical image analysis
SparkReceipt — AI-powered Receipt Scanner and Expense Tracker for Freelancers and Small Businesses. Get started for free now!
University of Eastern Finland — The University of Eastern Finland is a multidisciplinary university which offers teaching in more than 100 major subjects. The university comprises four faculties: the Philosophical Faculty, the Faculty of Science and Forestry, the Faculty of Health Sciences, and the Faculty of Social Sciences and Business Studies.

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570

Investment focus

Software, Manufacturing, Health Care
Funding Round, Series A, Series B
Finland, United States, Switzerland

Portfolio highlights

IQM Quantum Computers — IQM is the leading European quantum hardware company in superconducting circuits. We build quantum computers.
IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
DataCrunch.io — DataCrunch is a cloud service provider which facilitates utilization and integration of state of the art AI/ML models

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Investment focus

Biotechnology, Health Care, Artificial Intelligence
Seed, Pre-Seed, Funding Round
Finland, Sweden, Norway

Portfolio highlights

Farang — Farang is an AI research lab based in Sweden developing the next-generation of foundational Large Language Models. The company was founded in 2025 and consists of a team of highly experienced researchers, developers, entrepreneurs and business professionals, joined by prominent deep-tech VCs and angel investors.
Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.

Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Funding Round
Finland, United States, United Kingdom

Portfolio highlights

Swarmia — Build better software faster with insights that power your whole engineering organization. Get started with a demo or a free 14-day trial.
Inven — Save time by using AI to find companies. Inven scans millions of websites to provide comprehensive data on companies similar to your search criteria.
Ovido — Ovido company specialises in supply chain and product data automation, with a focus on providing full product traceability and the establishment of Digital Product Passports (DPPs).

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Series A
Finland, United States, Switzerland

Portfolio highlights

AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Pre-Seed
Finland, Sweden, Norway

Portfolio highlights

Atium — Clean water is one of the largest future challenges we stand before, and toxic pollutants are a large contributing factor. Heavy metals are some of the most toxic chemicals to human health and it is our goal, through our innovation, to contribute to a world where water treatment is more environmentally friendly and effective. Atium exists to helpensure clean water, for everyone.
Reactional Music — Reactional Music is creating a new commercial layer for the global games industry that uses premium, licensed music to drive both user acquisition and player engagement. The company’s technology allows developers and publishers to integrate commercial music at two critical points in the player lifecycle:- Music in User Acquisition – improvingconversion, ROI, and campaign lifespan in playable ads and performance marketing.- Music in Games – increasing retention, session length, and monetization through adaptive, personalized music experiences.Reactional’s platform combines a patented rule-based adaptive music engine, a licensed catalog of more than six million tracks, and an automated rights and royalty system. The technology is already integrated with Unity and Unreal and is deployed across live projects with leading publishers and studios.
Popit — Popit makes medication connected with a unique, medical grade solution. It tracks medication use automatically and reminds ONLY if you miss. Developed together with healthcare professionals.

The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.

Investment focus

Biotechnology, Health Care, Energy
Series A, Funding Round, Seed
Finland

Portfolio highlights

ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Investment focus

Software, Information Technology, Artificial Intelligence
Pre-Seed, Seed, Series A
Finland, Estonia, Sweden

Portfolio highlights

Lutso — Empowering older adults to live independently, safely, and with dignity. Lutso is the smarter way to support aging at home.
Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
NROC Security — Prevent data leaks, govern shadow AI, prove compliance, and save 50% on GenAI subscriptions

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Investment focus

Software, Health Care, Manufacturing
Seed, Funding Round, Series A
Finland, Denmark, Sweden

Portfolio highlights

Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

Investment focus

Biotechnology, Life Science, Water
Seed, Series A, Funding Round
Finland, Sweden, Denmark

Portfolio highlights

EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.

We fund futurebreakthroughs

Investment focus

Apps, Water, Energy
Seed, Funding Round, Series A
Finland

Portfolio highlights

StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
HYPERMINE — Hypermine a novel laser-based mineralogy sensing technology to optimize resource recovery and reduce the negative environmental effects of mining.
TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.

The Climate Fund focuses on combating climate change, boosting low-carbon industry and promoting digitalisation.

Investment focus

Energy, Renewable Energy, Sustainability
Debt Financing, Funding Round, Series A
Finland

Portfolio highlights

AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
Finland, Sweden, Denmark

Portfolio highlights

Klevu — Klevu Oy is a self-learning search engine that helps online retailers turn visitors into customers. Its search for SMEs focuses on fast, relevant search with actionable insights into shoppers’ search and easy self-service integration.Klevu Oy’s enterprise edition provides natural language search with ease of catalog maintenance and insights intoshopping experience. It is based in Helsinki, Southern Finland.
Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Steep — Business intelligence for modern companies. Steep lets anyone on your team stay on top of your data.

Leena Niemistö

Investment focus

Health Care, Software, E-Commerce
Seed, Funding Round, Pre-Seed
Finland, United States

Portfolio highlights

Rens Original — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.

Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.

Investment focus

Life Science, Biotechnology
Seed
Finland

Portfolio highlights

Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

Investment focus

Apps, Food Processing, Food and Beverage
Seed
Finland

Portfolio highlights

AIATELLA — Automating medical image analysis
Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Investment focus

Biotechnology, Health Care, Energy
Debt Financing, Post-IPO Debt, Funding Round
Germany, France, The Netherlands

Portfolio highlights

Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
Greenlight Biosciences — Next Generation Crop Protection
Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
Excelsior Sciences — Rebuilding the World, From the Bottom Up

Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.

Investment focus

Genetics, Hospital, Automotive
Funding Round
Finland

Portfolio highlights

R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of â‚¬56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!

VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?

Investment focus

Biotechnology, Manufacturing, 3D Technology
Seed, Funding Round, Series A
Finland

Portfolio highlights

Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.

Fazer Group mission is to create taste sensations. Customer orientation, quality and operations are based.

Investment focus

Biotechnology, Food Processing
Series A, Series B, Funding Round
Finland

Portfolio highlights

Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Seed, Debt Financing
United States, Israel, Denmark

Portfolio highlights

Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, The Netherlands, Switzerland

Portfolio highlights

Cyted — Cyted focuses on providing digital diagnostic infrastructure to drive the earlier detection of disease. Our technologies use AI and novel biomarkers to improve patient outcomes.
Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.

Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.

Investment focus

Health Care, Biotechnology, Therapeutics
Funding Round, Series A, Series C
Finland, The Netherlands

Portfolio highlights

Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.

Mikael Westerlund is the Founder and Chief Business Activist at Origin by Ocean.

Investment focus

Biotechnology, Environmental Engineering
Seed
Finland

Portfolio highlights

Origin by Ocean — We rid the oceans of harmful algae and turn it into everyday goods.

Master of Political Science (University of Helsinki), Master of Science (Econ.) (London School of Economics), Master of Science (Eng.) (Helsinki University of Technology).Chairman and CEO, Chairman of the Group Executive Board of Nokia Corporation 1999-2006, President and CEO, Chairman of the Group Executive Board of Nokia Corporation1992-1999, President of Nokia Mobile Phones 1990-1992, Senior Vice President, Finance of Nokia 1986-1989. Holder of various managerial positions at Citibank within corporate banking 1978-1985.Vice Chairman of the Board of Directors of Otava Ltd and member of the Board of Directors of Fruugo Inc. Member of the Board of Directors of the University of Helsinki. Chairman of the Boards of Directors and the Supervisory Boards of The Research Institute of the Finnish Economy ETLA and Finnish Business and Policy Forum EVA. Member of The European Round Table of Industrialists. Chairman of the World Business Council for Sustainable Development (WBCSD). Vice Chairman of the Independent Reflection Group of the Council of the European Union considering the future of the European Union.Member of the Board of Directors of Ford Motor Company 2000-2008. Vice Chairman of UPM-Kymmene Corporation 2004-2008.

Investment focus

Life Science, Market Research, Quantum Computing
Seed
Finland

Portfolio highlights

Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.

The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.

Investment focus

Apps, Hospital, Consulting
Seed, Grant, Pre-Seed
Finland, Luxembourg

Portfolio highlights

NADMED — The standard of NAD measuring
Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol

Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.

Investment focus

Software, Analytics, Semiconductor
Series A, Series B, Seed
Finland, United States, Sweden

Portfolio highlights

Neo4j — Connect data as it's stored with Neo4j. Perform powerful, complex queries at scale and speed with our graph data platform.
Blackwood Seven — Attribute, predict and optimize the business outcome of marketing and media plans with Blackwood Seven's Unified Marketing Modeling platform.
Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.

Zhejiang Huahai Pharmaceutical Co. Ltd. is a Phermaceutical Company.

Investment focus

Biotechnology, Pharmaceutical, Therapeutics
Series A
China, Finland

Portfolio highlights

Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Yannuo Pharmaceutical — Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conductsresearch and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas.

Midinvest Management is a Finnish private equity firm specialized in ownership arrangements for small- and medium-sized enterprises.

Investment focus

Software, Information Technology, Internet
Seed, Funding Round, Convertible Note
Finland

Portfolio highlights

Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
Quosis — As of March 18, 2008, Quosis Oy was acquired by Proactum Oy. Quosis Oy operates as an open source software service company. It offers open-source based solutions and services, including portal solution for managing organizationâ€™s information and services; content management for gathering, sharing, saving, and producing information; businessprocess management for automating, monitoring, managing, and improving key processes; integration of information systems; and instant messaging for improving the organizational information exchange. The company also offers open source consultation and software development services. It serves the paper industry. The company was founded in 2004 and is headquartered in Jyvaskyla, Finland.
Howspace — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.

Provide an effective, outsourced incubation and acceleration platform .

Investment focus

Electric Vehicle, Manufacturing, Energy
Funding Round, Seed, Pre-Seed
Finland, Norway

Portfolio highlights

Akkurate — Sandvik Battery Electric Loaders and Trucks TH550B LH518B Mobile Charging Station Battery as a Service
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
The Human Touch Robotics — Automating online grocery and food related goods picking with single-item picking robots, through adaptive gripping and AI vision system.

Metsola Ventures

Investment focus

Medical, mHealth, Health Care
Series A
Finland

Portfolio highlights

Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Synoste Oy — Patient friendly and innovative solutions for correcting skeletal deformations.

Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.
Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.

We are Valio Group: the most innovative dairy and food company in the world.

Investment focus

Life Science, Biotechnology
Series A, Series B
Finland

Portfolio highlights

Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.

Petri Pöyhönen

Investment focus

Medical, Biotechnology, Medical Device
Series A
Finland

Portfolio highlights

Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.

Dawn is Europe’s largest specialist B2B software investor, with assets under management of $1.5bn. Dawn partners with founders building the next generation of global software leaders, supporting them to harness extraordinary teams.Haakon has served on the boards of Self Trade and Wonga.com amongst others, and currently represents Dawn’sinterest at Conversocial, Crate.io, LeadDesk, Minute Media and Neo Technologies.Prior to formalising early stage investing at Dawn, Haakon worked with early stage companies from their first commercial efforts through to managing accelerated growth, often by serving as an interim manager or board member. They include G-Cluster (sold to Softbank Broadmedia) and Lateral Logic (sold to Electronic Arts).Mr. Overli studied Mathematics at the University of Oslo and holds a B.A. (Hons) in Economics from University of Durham.In his investment-banking career when the world was covered in ice, Haakon was a Director and Co-Head of Technology Investment Banking at ING Barings. Prior even to that, Haakon worked for JP Morgan in the M&A departments of New York and London.

Investment focus

Advertising, SaaS, Software
Series A, Series B, Series C
United States, United Kingdom, Finland

Portfolio highlights

Minute Media — We are a digital-first media company with a global footprint, bringing passion to life with proprietary technology that powers best-in-class content and advertising partnerships.
Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Crate.io — CrateDB is the leading open-source, distributed SQL database, empowering customers to turn data into business value

Founded in 2016, Wave Ventures is the largest student-run VC in Europe, backed by Nordic unicorn founders, investing in Gen Z entrepreneurs at the earliest stage. We operate both from Finland and Sweden with a team of five people from the top universities in the region.

Investment focus

Software, Mobile Apps, Information Technology
Seed, Pre-Seed, Funding Round
Finland, Sweden, Germany

Portfolio highlights

Bought — Everything you've bought, automatically ready for resale.
Sustashift — Sustashift offers a comprehensive legal CSRD reporting tool, providing tailored audit templates and automated XBRL tagging to streamline compliance and reduce manual reporting efforts.
Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.

We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.

Investment focus

Software, Health Care, Biotechnology
Series A, Funding Round, Series B
Germany, Switzerland, United States

Portfolio highlights

Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
Humanoo — HUMANOO | MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy.

The Stockholm Techstars Accelerator invests in early-stage, high-growth companies looking to build and expand in the Nordic-Baltic startup ecosystem.

Investment focus

Pet, FinTech, Finance
Pre-Seed
Israel, Norway, Sweden

Portfolio highlights

goscore — Fair human credit scoring, credit check, and assessment for you
Terrawaste — TerraWaste is a next-generation chemical recycling company that turns non-recyclable waste into value by creating new, climate-positive materials with a pollution-free process. TerraWaste focuses on lowering the level of need for virgin oil extraction by recycling plastics with chemical recycling technology 'htloop' into high-qualityclimate-positive crude oil, biochar, and high-value chemicals to support companies globally to become more sustainable and circular. Our technology (htloop) is developed on a process developed in the laboratory for over 20 years and hasn’t been commercialized until recently. TerraWaste is the first company to use HTL to recycle plastic waste and turn it into new plastic products. The unique thing is the state-of-the-art technological system that will recycle waste in a continuous-flow system, at the same time reusing heat and water in a loop, that way dramatically decreasing energy consumption. Our process is pollution free, and we produce carbon-negative output materials, that way offsetting other, carbon-heavy industries.
Five Letter Foods — Real food for dogs. Ultra-processed junk food is boring and makes your dog sick. Our meal kits have a full swing of variety. Death to kibble.

Aqua-Spark is an investment fund with a focus on sustainable aquaculture businesses around the world. The small-to-medium enterprises (SMEs) they invest in are working toward the production of safe, accessible aquatic life, such as fish, shellfish and plants, in ways that do not harm their oceans. Their investors value the fact that each investmentaims to create triple impact—specifically, each investment is chosen for its potential to generate significant financial returns while also activating positive environmental and social outcomes.Aqua-Spark believes that committing to a long-term vision is the way to realize effective and lasting impact results. When it comes to investments, they do not seek quick exits; instead, they look for entrepreneurs who strive to build and scale toward the future, who see their business as major economic opportunities that can also help solve looming environmental and food security challenges over the long-term. As an essential of each investee, Aqua-Spark seeks sustainability.

Investment focus

Biotechnology, Aquaculture, Seafood
Funding Round, Series A, Seed
United States, Norway, Israel

Portfolio highlights

Protix — Discover how Protix is revolutionizing the food system by converting organic waste into nutritious insect-based ingredients for a sustainable future.
XpertSea — XpertSea is a Canadian technology company that's transforming how the global aquaculture industry farms seafood to help feed the world. Combining smart aquaculture equipment with a farm management platform, our collaborative solution uncovers actionable insights driven by artificial intelligence. These insights enable farmers and industryexperts to optimize feed efficiency, reduce environmental waste, take preventive actions against diseases and use data to bring transparency and knowledge to the entire supply chain. With customers in over 50 countries, we’re using Canadian ingenuity to make aquaculture profitable and sustainable.
Proteon Pharmaceuticals — Proteon Pharmaceuticals serves livestock and aquaculture farms that aim for high-quality and sustainable protein production.

We provide venture capital for companies with cutting-edge technology that solves key issues in the transition to a net zero emissions world.

Investment focus

Manufacturing, Energy, Software
Funding Round, Series B, Series A
United States, Germany, Canada

Portfolio highlights

sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
INDRA — Smart and decentralized Water Treatment Systems
Colibri Energy — Colibri Energy - Lithium Batteries produces battery solutions for GSE & Logistics to reduce costs of operations and provide sustainable alternatives.

Kristian Ranta is a Co-Founder & Chief Executive Officer at Meru Health.

Investment focus

Health Care, Apps, Internet
Seed, Pre-Seed
Finland, United States

Portfolio highlights

AIATELLA — Automating medical image analysis
Solu — Discover the next generation toolkit for analyzing, storing and sharing bacterial genomes.
Vital — Vital API allows developers to access health data from wearable devices and at-home test kits. The company was founded in 2021 by Maitham Dib and is headquartered in San Francisco, California, United States.

Athensmed Oy

Investment focus

Health Care, Medical, mHealth
Seed, Series A, Funding Round
Finland

Portfolio highlights

VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol

Feroz Dewan is the chief executive officer at Arena Holdings.

Investment focus

Life Science, Market Research, Quantum Computing
Seed
Finland

Portfolio highlights

Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.

Riitta Ekengren is an Angel Investor.

Investment focus

Biotechnology, Environmental Engineering
Seed
Finland

Portfolio highlights

Origin by Ocean — We rid the oceans of harmful algae and turn it into everyday goods.

We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Series A
Germany, United Kingdom, Finland

Portfolio highlights

Elio — Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence.
Ocean Ledger — Precision analytics to design, implement & monitor coastal mitigation and adaptation.
NatureMetrics — NatureMetrics is the World-Leading provider of Biodiversity monitoring data, using eDNA surveys, metabarcoding & more. Book your demo today!

Fortum Oyj is a global learning and development firm specializing in strategy execution for companies in a broad array of industries.

Investment focus

Biotechnology
Series A
Finland

Portfolio highlights

Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.

Oy Hammaren & Co Ab provides financial services and insurance activities.

Investment focus

Health Care, Wellness, GreenTech
Funding Round, Angel, Series A
Finland

Portfolio highlights

Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
Heltti — We are Heltti! We help people and knowledge workplaces feel better.
NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.

Granström Mari is the Chief Science Activist at Origin by Ocean.

Investment focus

Biotechnology, Environmental Engineering
Seed
Finland

Portfolio highlights

Origin by Ocean — We rid the oceans of harmful algae and turn it into everyday goods.